Current hypotheses consonant with the peak in leukemia incidence in early childhood point to an infectious etiology. The authors examined the effect of postnatal exposures predicted to affect early immune functioning, including childhood vaccinations, illness, medication use, and breastfeeding patterns. Children 0-15 years of age diagnosed with leukemia from 1990 to 1994 and resident within principal cities across Canada were eligible for inclusion. Through pediatric oncology centers and population-based cancer registries, 399 cases were ascertained at the time of diagnosis. For each participating case, an age-, gender-, and area-matched control was randomly selected from government health insurance rolls. Risk factor information was obtained through personal interviews with each child's parents or guardians. Conditional logistic regression was used to calculate odds ratios, with adjustment for potential confounders. Use of immunosuppressant medication by the index child led to a deficit of risk (odds ratio ¼ 0.37, 95% confidence interval: 0.16, 0.84), while vitamin intake was positively associated with leukemia (odds ratio ¼ 1.66, 95% confidence interval: 1.18, 2.33). Breastfeeding for more than 6 months was also protective (p < 0.05). Results persisted for cases diagnosed with acute lymphoblastic leukemia and for children diagnosed at 1-5 years of age. These findings suggest a role for early immunologic challenge in the expression of childhood leukemia.
postulated that exposure to common infections in infancy or early childhood could lead to improved immunologic resistance during subsequent challenges, while delayed exposure could lead to an aberrant response resulting in leukemia among children who had not otherwise developed immunity. Support for an infectious etiology has also been provided from studies of space-time clustering and population mixing (5) (6) (7) (8) (9) (10) (11) . However, the evidence remains inconclusive, and results from case-control studies of postnatal exposures and immune susceptibility factors, including infections, vaccination, breastfeeding, and social mixing, have been contradictory (5, 12, 13) . The inconsistency in results across studies may reflect differences in control selection, statistical power, and histologic subtypes of leukemia investigated.
As part of a five-province consortium across Canada, we evaluated the association between childhood leukemia and a variety of clinical, environmental, and genetic risk factors. Study findings have previously shown no relation between electromagnetic fields and risk of childhood leukemia (14) . This analysis explores the effect of exposures incurred after birth to determine risk associated with factors affecting early immune development, including childhood vaccination, illness, medication use, and infant breastfeeding.
MATERIALS AND METHODS

Study population and data collection
Children aged 0-14 years, diagnosed with leukemia between January 1, 1990 , and December 31, 1994 (June 30, 1995 , in British Columbia and Quebec), and resident within 100 km of the principal cities of Alberta (Edmonton and Calgary), British Columbia (Vancouver and Victoria), Saskatchewan (Saskatoon), Manitoba (Winnipeg), and Quebec (Montreal) were eligible for inclusion in the study. Participants meeting these criteria were ascertained through pediatric oncology treatment centers in each of the five provinces. Population-based cancer registries were also used for case ascertainment in all provinces except Quebec. Residential eligibility criteria were defined as living within a census tract area within 100 km of one of the study sites. The centroid of each census tract was defined as the geographic center of each city's regional health area. During the first year of the study, ascertainment was retrospective. From 1991 forward, cases were approached within 6 weeks after diagnosis and notification from pediatric oncology centers. All diagnoses were verified through receipt of hematology and pathology reports, and residential eligibility was verified at the time of initial contact with the child's parents or guardians. Provincial cancer registry records were also reviewed on a continuing basis to ensure that cases were not missed. Cases with Down's syndrome, an associated genetic condition, were deemed ineligible because of the known relation with leukemia.
For each participating case, an age-, gender-, and areamatched (based on residence within the same census tract) control was randomly selected from the provincial government health insurance rolls. Each insurance roll included virtually the entire provincial population with the exception of those residing in the province less than 3 months. In Quebec, family allowance rolls were used in addition to government insurance lists for control selection during the first 2 years of the study. Since application for family allowance results in financial benefits, registration of new births is complete. Matching on age was within 6 months for cases diagnosed at age 2 years or older and within 3 months for cases diagnosed before 2 years of age. Initial contact with potential controls was by letter, followed by telephone contact. In total, 449 cases and 675 controls were identified as possible subjects. Of these, 445 cases and 526 controls eligible for inclusion in the study were successfully contacted. A total of 399 case-control pairs agreed to participate, resulting in contact participation rates of 90 percent for eligible cases and 76 percent for eligible controls. Risk factor information was obtained through standardized, personal interviews conducted in the home with the child's parents or guardians. Whenever possible, interviews were conducted with both parents together, and interpreters were available if the subject's family spoke neither English nor French. Information was collected on specific vaccinations, illnesses, and medication use in childhood, including the age at first exposure and duration of exposure (for medication use). Immunization data were recorded from the child's vaccination record if available at the time of interview. Otherwise, parents were asked to recall their child's immunization history. Parents were also asked about the index child's feeding patterns at specific ages during the first year of life, and whether this included exclusive breastfeeding or milk supplementation. Interviewers were not informed of the case-control status of the child; however, blinding could not be ensured since interviewers may have become aware of the disease status of the child during the interview.
Data analysis
Risk factors for childhood leukemia were examined by use of standard case-control methods (15). Pearson's chi-square was used to compare demographic and socioeconomic characteristics between cases and controls. Conditional logistic regression was used to estimate odds ratios and 95 percent confidence intervals as approximations of relative risks, with adjustment for potentially important confounding variables deemed significant (p < 0.05 or odds ratio (OR) 1.5 and p < 0.10) in a preliminary exploration of the data, including maternal education, annual household income, ethnicity, maternal age at birth, and number of residences since birth. The multivariate models relied on strata formed by the following matching factors: province, gender, and age (<1.5, 1.5-4, 5-9, and 10-14 years). This stratified analysis proved to be more efficient than a matched analysis, and it avoided loss of information due to cases that could not be matched to a comparable control subject. Exposures that occurred within 6 months of diagnosis (pseudodiagnosis in controls) were not counted during analyses. Results are presented for the overall study group, as well as for cases diagnosed with acute lymphoblastic leukemia (ALL). We also examined risk according to the timing of exposure (those occurring within the first year of life and later) and for different age groups (those diagnosed at 1-5 years and 6-14 years). Statistically significant risk factors for childhood leukemia were indicated by a significance level of p < 0.05 (two-sided test). Tests for trend for continuous predictor variables were also conducted with statistical significance indicated by p < 0.05.
RESULTS
The majority of cases in our study were diagnosed with ALL (88 percent), followed by acute myeloid leukemia (10 percent) and other non-ALL subtypes (2 percent). The distribution of subtypes across age strata reveals that most cases of ALL were diagnosed among children 1-5 years of age (65 percent), while the majority of non-ALL cases were diagnosed in infants less than 1 year of age or children aged 6-14 years (69 percent). As presented in table 1, cases and controls were comparable according to their age and gender distribution because of study selection criteria. However, cases had a lower overall socioeconomic status (as measured by parental income and education) and had lived in more residences prior to diagnosis than had control subjects. There was also a higher proportion of case mothers who gave birth to the index child at a younger age, particularly before the age of 25 years.
Information on the child's medical history allowed for examination of the relation between childhood leukemia and immunization, illness, and medication use. No association was found between childhood leukemia and exposure to several common vaccines, including the measles, mumps, and rubella (MMR), diphtheria, tetanus, and pertussis (DTP), poliomyelitis, hepatitis, or Bacillus Calmette-Guérin (BCG) vaccines, although the number of unvaccinated (or vaccinated for hepatitis and BCG) subjects was very small for some groups (table 2). Although it is expected that the proportion of subjects unexposed to MMR, DTP, and poliomyelitis vaccines would be low because of Canada's national immunization strategy, these results should be interpreted with caution. Assessment of risks for ALL subtypes or by age at diagnosis did not change our findings. However, a nonsignificant inverse association with leukemia was observed for children that received the MMR vaccine after 1 year of age, with odds ratios approaching a 50 percent deficit of risk (for measles: OR ¼ 0.49, 95 percent confidence interval (CI): 0.20, 1.18; for mumps: OR ¼ 0.43, 95 percent CI: 0.18, 1.02; and for rubella: OR ¼ 0.51, 95 percent CI: 0.23, 1.12). Information on exposure to each vaccine was collected separately, and if the child's immunization record was not available at the time of interview, parents were asked to recall their child's vaccination history. Therefore, a different proportion of parents responded that the index child had received each of the three vaccines when, in fact, the MMR vaccine is administered as one shot in combination.
Several illnesses and common infections in childhood, including measles, mumps, rubella, chicken pox, and ear infections, were not associated with leukemia in the overall study group or among cases diagnosed with ALL (table 3) . No relation between illness in childhood and childhood leukemia was found when data were examined according to age at diagnosis or timing of exposure (data not shown). ) . Several other common prescription drugs (blood pressure medication, hormones, thyroid medications, antiepileptic drugs, and sedatives) and over-the-counter medications (diuretics, diet pills, and antiinflammatory medications) were examined but either showed no significant relation with childhood leukemia or had too few cases to allow for meaningful interpretation of the results (data not shown). Information on indications for the use of specific medications taken by the index child was not available.
The results of an analysis of infant feeding patterns are shown in table 5. The model, adjusted for maternal age at birth and socioeconomic status, showed milk supplementation to be positively associated with childhood leukemia. The relation was strongest among infants 7-12 months of age who had received milk supplementation more than 50 percent of the time (OR ¼ 1.79, 95 percent CI: 1.11, 2.89). However, a longer duration of exclusive breastfeeding was not suggestive of a protective effect (p > 0.05).
DISCUSSION
Greaves (2) and Greaves and Alexander (4) have proposed that factors that elicit an immune response in infancy or early childhood, including exposure to common infections, could be protective for childhood leukemia. Our study was designed to identify postnatal factors associated with childhood leukemia that might test this theory, including exposure to common illnesses, immunization, medication use, and breastfeeding. After adjustment for socioeconomic status and other maternal reproductive factors, a negative association between use of immunosuppressant medications in childhood and breastfeeding for longer than 6 months was observed. Conversely, use of vitamins in early childhood led to an increased risk of childhood leukemia.
Studies of vaccination in infancy or early childhood have generally reported a protective effect on the risk of childhood leukemia (16) (17) (18) (19) , although findings vary according to the type of vaccine and the age at immunization. Decreased risks of leukemia have been associated with measles vaccination (16) , DTP vaccination (17), Haemophilus influenzae type B (Hib) vaccination (20) (21) (22) , and BCG vaccination for tuberculosis (16) . Timely completion of early childhood immunizations may decrease the risk of leukemia through general improvements in immune functioning (2, 4) . Vaccination in childhood would also be consistent with higher levels of herd immunity (natural immunization), which may also reduce risk (7, 23) . We observed a protective effect of MMR vaccination on childhood leukemia risk, but only among children immunized after 1 year of age, and odds ratios were only marginally significant (p < 0.10). Results persisted after adjustment for indicators of socioeconomic status, suggesting that control selection bias was not responsible for our findings. Any residual confounding by socioeconomic status is unlikely given that routine childhood immunizations are delivered universally under a publicly funded healthcare system in Canada. However, the proportions of cases and controls receiving each of the three vaccines were not identical, which points to the possibility of exposure misclassification since MMR is administered as a combination vaccine. There were also a very small number of unvaccinated subjects, which further limits interpretation of our findings.
Support for an infectious etiology for childhood leukemia has also been derived from studies of early illness and common childhood infections. Although no one infectious agent has been identified, decreased risks of leukemia have been reported among children with prior measles, mumps, hepatitis A, and ear infections, as well as nonspecific viral infections (16, 18, (24) (25) (26) . We found no association between childhood leukemia and any of these illnesses or infections. It is plausible that differences in the age at infection, type of infection, and timing of exposure could account for the divergent trends across studies. For instance, Chan et al. (27) reported a decreased risk of leukemia following infectious exposure during the first year of life, while infection in the year prior to diagnosis led to an increased risk. Others have observed a similar protective effect of infection during the first year of life (25, 28) or through early childhood (26), but not among older children. We measured illness from birth to diagnosis, and separately for exposures during the first year of life and later, with no indication that risk was related to a critical window of exposure.
Our study is one of but a few studies to examine the potential effects of early medication use on the risk of childhood leukemia. The use of chloramphenicol antibiotics has previously been shown to increase risk for both the ALL and acute nonlymphocytic leukemia subtypes in a case-control study from China (29), but we could not confirm this association because too few cases (n ¼ 1) and controls (n ¼ 2) had reported use of chloramphenicol. Our study also showed no association between childhood leukemia and common medications such as aspirin and allergy remedies. Although cautionary because of small numbers, a protective effect was observed for use of immunosuppressant medications in childhood, which would lower the body's natural defense system, thereby leading to an increased susceptibility to infection and possibly early immunologic challenge. A positive relation between childhood leukemia and use of vitamin supplements also supports a role for immune development in the etiology of childhood leukemia. Because controls were of a higher socioeconomic status than cases, it is possible that control participation bias may have influenced these results. However, it is expected that children of higher socioeconomic status would have better access to nutritional supplements than children of lower socioeconomic households, which would bias our result toward the null. Furthermore, our findings were strengthened owing to the persistence of significant relations when risk was examined for ALL subtypes, for children diagnosed in early childhood, and for exposures occurring within the first year of life and later.
Several studies have shown a protective effect of prolonged breastfeeding on risk of childhood leukemia (26, (30) (31) (32) (33) , although results remain equivocal (5, 18, 19, 34, 35) . We found that mixed feeding with a higher proportion of milk supplement (breast milk þ >50 percent milk supplementation) after 6 months of age led to an increased risk of childhood leukemia in comparison with exclusive breastfeeding. Human milk contains an array of microbial activity, and it is postulated that breastfed infants are less susceptible to infection because of early development of the immune system in comparison with artificially fed infants (2, 4, 35) . Breastfed infants may also be exposed to infectious agents transferred from the mother's milk, thereby leading to early exposure to infectious organisms and development of natural antibodies (35) . We found the relation with milk supplementation to be more pronounced for infants 7-12 months of age compared with early infancy, although a longer duration of exclusive breastfeeding was not associated with greater sustained protection.
Inherent in our case-control study is the possibility of selection or recall bias, as well as exposure misclassification, since information was not always corroborated with the index child's vaccination or medical records. We Table continues 604 MacArthur et al.
improved upon traditional retrospective designs by collecting risk factor data close to the time of diagnosis, thereby minimizing loss to follow-up. We also ensured essentially complete ascertainment of cases from cancer registries, acute-care hospitals, cancer treatment centers, and hematology and pathology laboratories. Controls were selected from population-based health insurance claims as part of the provincially administered public health system in Canada, resulting in a representative sample of study participants. However, given the large number of statistical tests conducted, some of our results might be chance findings from multiple comparisons.
In conclusion, our study highlights a potential role for immune development in the expression of childhood leukemia. Our results are congruent with the current hypothesis put forth by Greaves that states that reduced antigenic challenge during early postnatal development may contribute to an increased risk of childhood leukemia (36) . Information on risks associated with immunosuppressant medication and vitamin supplementation in relation to the timing of exposure (infancy vs. later childhood) strengthens the interpretation of our results in accordance with Greaves' hypothesis. Nonetheless, these relations need to be investigated further with respect to possible mechanisms of induction and to explicate potential interactions with other predisposing characteristics, in both the perinatal and the postnatal stages of development. 
